Company Remysan Med S.r.l. with Fiscal Code 13838247
recorded a turnover of 2024 of
115.857,
with a net profit of
51.176
and having an average number of employees of
3.
The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Remysan Med S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
42.203
41.155
46.513
50.954
63.756
68.770
71.838
79.163
93.597
115.857
Total Income - EUR
42.257
41.156
46.514
51.480
63.758
72.316
71.840
79.359
94.191
117.113
Total Expenses - EUR
40.742
43.174
46.601
47.708
52.432
54.100
52.816
51.232
53.383
62.424
Gross Profit/Loss - EUR
1.515
-2.017
-87
3.771
11.325
18.216
19.025
28.127
40.808
54.689
Net Profit/Loss - EUR
245
-2.429
-552
3.256
10.687
17.762
18.318
27.371
39.866
51.176
Employees
3
3
3
3
3
3
3
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 24.5%, from 93.597 euro in the year 2023, to 115.857 euro in 2024.
The Net Profit increased by 11.532 euro, from 39.866 euro in 2023, to 51.176 in the last year.
Check the financial reports for the company - Remysan Med S.r.l.
Financial Rating - REMYSAN MED S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Remysan Med S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Remysan Med S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Remysan Med S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Remysan Med S.r.l. - CUI 13838247
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
0
0
0
0
492
892
273
0
0
2.139
Current Assets
13.824
11.115
10.415
13.721
23.398
28.238
30.700
40.190
52.995
61.307
Inventories
472
0
0
203
0
0
0
0
0
0
Receivables
1.052
1.041
1.160
1.716
1.427
1.610
2.063
1.072
7.202
2.265
Cash
12.300
10.074
9.255
11.802
21.971
26.627
28.637
39.118
45.793
59.041
Shareholders Funds
11.098
8.313
7.621
10.737
20.853
27.735
28.070
37.153
49.619
60.874
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
2.909
2.982
2.972
3.168
3.217
1.571
3.076
3.210
3.549
2.572
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8621 - 8621"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
61.307 euro in 2024 which includes Inventories of
0 euro, Receivables of
2.265 euro and cash availability of
59.041 euro.
The company's Equity was valued at
60.874 euro, while total Liabilities amounted to
2.572 euro.
Equity increased by 11.532 euro, from 49.619 euro in 2023, to 60.874 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Remysan Med S.r.l.